For many years, the cloning of adults, animals or humans has been mostly the object of science fiction, something unforeseen by man. However, "The world was shocked in February of 1997 when British scientist, named Ian Wilmot announced that his research team successfully cloned lamb named dolly from an adult sheep at the Roselyn Institute in Scotland".(1) For what seemed like a dream for many years quickly turned into reality. The newest and possibly the most controversial phenomena in curing human disease, a phenomenon better known as cloning, was born. .
Through out the history of man, human disease has been considered a leading cause of death. Since antiquity, physicians explored assorted remedies in order to cure various maladies. Ancient physicians made enormous contributions to modern medicine. Even though, immaculate progress has been made in modern medicine, there are numerous cases of fatal diseases, for which modern medicine has no cure. Granted today's technological advancements, general practitioners are still using several of the ancient techniques and ideas in order to make progress in today's research and development. Scientists observe historical data and ideas in order to help generate new ones. A well known belief to man, the belief of reincarnation came from the ancient Egyptians who believed that there was life after death and preserved the body of their rulers through a process of mummification. This is a process of preservation that kept the original body and shape of the ruler for his/her return to earth. Although, this may seem a bit anomalous to the western man, contemporary technology brings this the idea of reincarnation or recreation to life, creating new ways to fight disease. Modern science takes the idea of human life and it's regeneration and brings it to life through the process of cloning. In 1938 a German scientist Hans Spemann proposes a "fantastical experiment" to transfer one cell's nucleus into an egg without a nucleus, the basic method that would eventually be used in cloning.